Pharma research jobs on the chopping block
Announcements of job loss in big pharma continue, with the UK press saying that GlaxoSmithKline will soon announce 4,000 layoffs, nearly half in R&D. linkurl:(The Guardian); AstraZeneca said last week it would cut 8000 jobs, 3,500 of them in R&D, and noted plans to outsource more of its research and trim the number of disease areas on which the company focuses. linkurl:(Wall Street Journal Health Blog);
Image: Wikipedia
FDA slaps doc for skin treatment statements
In a rare case of the agency censuring an individual rather than a company, the US Food and Drug Administration issued a warning letter to Miami Beach clinical researcher and dermatologist Leslie Baumann for "expressing premature enthusiasm" over a not-yet-approved injectible anti-wrinkle drug, the New York Times linkurl:reports.; The linkurl:letter,; issued last month, says Baumann improperly promoted the drug in statements to the media in...
Stem cells: an approval and some grants
A homeopathy protest
The IndependentPhD thesis, anyone?

Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?